Ximedica, Quartesian, Boston Healthcare Associates combine into Veranex

Private equity firm Summit Partners has acquired Ximedica, Quartesian and Boston Healthcare Associates — rolling them into a new medtech service company called Veranex.

In its inaugural news release on June 16, the new Raleigh, N.C.- based company touted itself as the first concept-to-commercialization global service provider — with capabilities including design and engineering, regulatory, clinical, and market access.

The financial terms of the deal were not disclosed. Veranex’s leadership includes CEO David Dockhorn, whose 32 years of life sciences experience includes co-founding a full-service contract research organization sold to Carlyle in 1997 and integrated into PRA Health Sciences. In addition, executive chair Pat Donnelly has more than 25 years as a pharma services founder and executive, serving as CEO of Advarra until last year.

“We are thrilled to partner with Pat Donnelly, David Dockhorn, and the rest of the Veranex management team to …

Read more
  • 0

Ximedica boosting its connected device offerings with KeborMed partnership

Ximedica (Providence, R.I.) recently announced that it has inked a partnership with KeborMed to boost its connected device development capabilities.

Cleveland-based KeborMed offers a Connected Care Platform that it touts as a plug-n-play approach that replaces custom development with a turnkey solution, drastically reducing the cost and time to market traditionally associated with the development of connected medical solutions.

“We are excited to partner with KeborMed to enhance our capabilities in the development of connected medical solutions,” Michael Pereira, president and COO of Ximedica, said in a July 20 news release.

“We are seeing enormous demand from our clients for the rapid implementation of connected medical devices, particularly as a result of the Covid-19 pandemic dramatically accelerating the development of telehealth and remote patient monitoring solutions,” Pereira said. “Adding KeborMed’s capabilities to our offering will s…

Read more
  • 0